Back to
Macquarie Group Ltd.
CHRS
29 quarters
Position history for
Macquarie Group Ltd.'s holdings in Coherus Oncology, Inc.
No. Macquarie Group exited its CHRS (Coherus Oncology) position in Q4 2025. Its Q3 2025 13F listed 899,999 shares worth $1.5M. Macquarie Group already held CHRS in its Q4 2018 13F, the earliest on record, and held it in 28 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$3.9M
Total Shares Change
-430,300
Quarter-by-Quarter History
Other major holders of CHRS: Temasek Holdings (Private) Ltd, Wellington Management Group LLP